Atul Pande - 10 Jan 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Director
Signature
/s/ Eva Renee Barnett, attorney-in-fact for Atul Pande
Issuer symbol
IMVT
Transactions as of
10 Jan 2022
Net transactions value
$0
Form type
4
Filing time
12 Jan 2022, 15:56:20 UTC
Previous filing
03 Jan 2022
Next filing
02 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Award $0 +21,726 +54% $0.000000 61,926 10 Jan 2022 Direct F1, F2
holding IMVT Common Stock 5,000 10 Jan 2022 By Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMVT Stock Option (right to buy) Award $0 +71,492 +52% $0.000000 208,973 10 Jan 2022 Common Stock 71,492 $7.94 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying restricted stock units awards ("RSUs").
F2 The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
F3 These shares are owned by a trust (the "Trust"). Certain members of the Reporting Person's immediate family are beneficiaries of the Trust.
F4 Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney